LeonaBio, Inc. LONA
Biotechnology: Biological Products (No Diagnostic Substances) · IPO 2020 · data as of November 13, 2026
LeonaBio, Inc. (LONA) is a healthcare company listed in the US with a market value of about $33M.
Its overall Stock Analiz score is 0.2 out of 5 (weak). The strongest part is financial health (1/5); the weakest is value (0/5).
Key numbers: a 5-year average ROIC of -116%.
About LeonaBio
LeonaBio is listed in the US and classified in biotechnology: biological products (no diagnostic substances), IPO year 2020. It was profitable in 0 of the last 7 years in our data. Its share count rose by 13% over three years (dilution for shareholders).
Score: 0.2 / 5
Checks passed
- More cash than debt, or low debt to equity
Checks not passed
- P/E below 25
- P/E below the industry median
- P/FCF below 20
- Price below intrinsic value (DCF, moderate assumptions)
- PEG below 1.5
- Revenue growth above 10% last year
- 3-year revenue growth above 10% a year
- Profit margin improving
Valuation
Growth and quality
Financials, last 7 years
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — |
| Net income | -$106M | -$97M | -$118M | -$96M | -$55M | -$20M | -$5M |
| Free cash flow | — | -$97M | -$101M | -$74M | -$45M | -$26M | — |
| EPS (diluted) | $-24.70 | $-25.19 | $-30.90 | $-25.30 | $-14.90 | $-16.70 | $-14.50 |
| Net margin | — | — | — | — | — | — | — |
| ROIC | -282.6% | -173.1% | -75.2% | -34.7% | -15.7% | -5.7% | — |
From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.
Frequently asked questions
Does LeonaBio pay a dividend?
Not currently.
Is LeonaBio a good stock to buy?
We do not give buy or sell advice. LeonaBio scores 0.2 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.
Similar companies
Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.